Postinjection delirium/sedation syndrome with olanzapine depot injection
After 1 year of introduction of olanzapine long-acting injectable (LAI) in India, many psychiatrists believe that it is a very affordable, well-tolerated, and effective second generation long-acting antipsychotic depot compared to not well tolerated but cheap first generation antipsychotic depots an...
Main Authors: | Sadhvi Mythili Sarangula, Starlin Vijay Mythri, Y Sanjay, M S Reddy |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-01-01
|
Series: | Indian Journal of Psychological Medicine |
Subjects: | |
Online Access: | http://www.ijpm.info/article.asp?issn=0253-7176;year=2016;volume=38;issue=4;spage=366;epage=369;aulast=Sarangula |
Similar Items
-
Post-injection syndrome and olanzapine long-acting injection in patients with schizophrenia: A case series
by: Saheli Dey, et al.
Published: (2022-12-01) -
An unusual complication of a long-acting injectable antipsychotic: deep venous thrombosis caused by olanzapine pamoate
by: Serhat Tunç, et al.
Published: (2018-04-01) -
Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data
by: Detke Holland C, et al.
Published: (2012-05-01) -
Postinjection delirium/sedation syndrome in a transgender man undergoing hormone therapy
by: Joshua Gerving, PharmD, BCPS, BCPP, et al.
Published: (2023-08-01) -
Dexmedetomidine versus Propofol Sedation for Prevention of Postoperative Delirium: Clarifications Required [Letter]
by: Deng J, et al.
Published: (2021-07-01)